Altamimi, M., et al
Proper storage conditions help maintain peptide purity, structural integrity, and stability for reliable experimental use
Common side effects (may affect up to 1 in 10 people): * Pain, redness, or swelling at the injection site * Nausea * Headache Uncommon side effects (may affect up to 1 in 100 people): * Diarrhea * Dizziness * Allergic reactions such as skin rash, itching, or hives Rare side effects (may affect up to 1 in 1,000 people): * Severe allergic reaction (anaphylaxis) with symptoms like difficulty breathing, swelling of the face or throat, and a drop in blood pressure
Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists | Diabetes | JAMA | JAMA Network
The firm has not published data beyond the press release, but it appears that those who take GLP-1s have much higher costs in the first year, and their inflation rate in year two is lower than those not on GLP-1s